DUBLIN–BUSINESS PHONE–The “DNA Methylation Market Size, Share & Trends Research Report By Technology (PCR, Microarray, Sequencing), By Application (Genesis, Research), By Product, By End-Use, By Region, and Segment Forecasts, 2022 – 2030” added to the report ResearchAndMarkets.com’s sacrifice.
The global DNA methylation market size is expected to reach USD 4.22 billion by 2030. The market is expected to register a CAGR of 14.67% from 2022 to 2030, due to the increasing use of DNA methylation in sequencing research. The growing acceptance of DNA methylation in the agrigenomics field has been a strong driver of this development.
In January 2020, a research journal published in Springer stated that DNA methylation and expression analysis showed that peanut foliar disease resistance genes have epialleles. DNA methylation research continues to open new doors of opportunity for researchers, and pharmaceutical companies. Increasing research and development in this field will further drive the DNA methylation industry in the coming years.
Furthermore, the development of esophageal adenocarcinoma contributed to the overall development. According to the data published by the American Cancer Society (ACS), in 2022, an estimated 20,640 esophageal cancer cases were not detected in the United States. The disease caused 16,410 deaths.
The growth of esophageal cancer in the United States indicates an urgent need for early intervention measures that can help improve the quality of life for patients. In October 2022, a research article published by the Fred Hutchinson Cancer Center revealed that methylated DNA biomarkers can be used to detect esophageal adenocarcinoma and high-grade dysplasia.
High adoption of epigenetics-based therapeutic strategies, coupled with major nucleic acid-based diagnostic tests & tools marketing is predicted to drive the market growth. In May 2022, an article published in PubMed stated that the drug-based treatment strategy will be used to study Alzheimer’s disease. However, lack of expertise to perform DNA methylation tests can limit growth. DNA MEHYYRAN WORKING LIFE IN WORKING IN THE SECOND SECTOR, while the number of skilled professionals has been an obstacle to progress.
The DNA Methylation Market Report highlights
The progress is generally attributed to the increased uptake of DNA methylation in research sequences in genetics and genomics and agrigenomics fields.
By technology, the sequencing segment will have the largest share in 2021, due to the increasing adoption of sequencing technology for research purposes by many businesses.
By product, the hardware segment dominates the market as it is widely used in DNA sequencing and diagnostic systems.
By application, the clinical research sector dominates the market due to the rise in the number of clinical trials for various diseases worldwide, and government support continues to drive the increase in R&D spending.
By end-use, pharmaceutical and biotech companies dominate the market, thanks to the increased use of advanced technologies such as NGS by large businesses.
North America dominates the market in 2021 due to its extensive manufacturing network and R&D facilities. Increasing number of product launches, FDA approvals, and the presence of major market players have been driving growth in this area.
Encouraging Adoption of DNA Methylation Technology in Oncology Research
The Global Prevalence of Cancer
Development of DNA Methylation as Epigenetic Biomarkers
Lack of Expertise and Psychology for Conducting DNA Methylation Tests
Undertaking DNA Methylation as a Commercial Diagnostic Test
Key topics covered:
Chapter 1 DNA Methylation Market: Approach and Support
Chapter 2 DNA Methylation Market: An Overview
Chapter 3 DNA Methylation Market: Industry Situation
Chapter 4 DNA Methylation Market: National Competition
Chapter 5 DNA Methylation Market: Technical Market Analysis
5.1 DNA Methylation Market: Technology Movement Analysis
5.2 Polymerase chain reaction (PCR)
Chapter 6 DNA Methylation Market: Product Market Analysis
6.1 DNA Methylation Market: Product Dynamics Analysis
6.3 Kits & Reagents
6.5 Hardware & Software
Chapter 7 DNA Methylation Market: Application Market Analysis
7.1 DNA Methylation Market: Application Dynamics Analysis
7.2 Blood Treatment
7.3 Clinical examination
Chapter 8 DNA Methylation Market: End-Use Market Analysis
8.1 DNA Methylation Market: End-Use Analysis
8.2 Hospital & Laboratories
8.3 Pharmaceutical & Bioscience Companies
8.4 Research & Education
Chapter 9 DNA Methylation Market: Regional Market Analysis
Chapter 10 DNA Methylation Market: Company Profiles
New England Biolabs
Sysmex Corporation growth
Abcam plc growth
F. Hoffmann-La Roche Ltd. bulk
Diagenode Diagnostics SA
Thermo-Fisher Scientific Inc. bulk
Provided by Agilent Technologies Inc.
Biorad Laboratories Inc.
Equal Sciences Corporation
Qiagen NV growth
Active Motif, Inc.
Illumina Inc. bulk
Epigentek Group Inc. bulk
Features provided by Pacific Biosciences, Inc.
New England Biolabs Inc. bulk
Zymo Research Corporation stock price
Perkinelmer Inc. bulk
For more information about this report visit https://www.researchandmarkets.com/r/ys2809.
ResearchAndMarkets.com is the world’s leading source for global market research reports and market information. We provide you with the latest information on global and regional markets, major industries, major companies, new products and the latest events.